Is the news out of the Trump White House giving us all FOMO (fear of missing out, that is), and making it impossible for other stories to be in the spotlight? CNN media reporters Oliver Darcy and Frank Pallotta talked about that with Brian Stelter in the most recent Reliable Sources podcast.
The two discussed the major media storylines of the week, including the live broadcast of O.J. Simpson’s parole hearing on multiple networks.
Nielsen reported that a mere 13 million people tuned in across the country, a sharp decline from the 150 million viewers who in 1995 watched Simpson’s murder trial verdict being announced.
By comparison, James Comey’s Senate testimony on June 8 drew in nearly 20 million viewers across 10 networks. Something about the Comey hearing made it feel like a “season finale,” Pallotta told Stelter, an event that “had everyone glued to their screen for hours,” Darcy added.
In times when Washington is a source of intrigue and mystery, people are engrossed by the breaking news cycle more than they are by their favorite TV series or other forms of entertainment. Darcy asked: “Who has time to watch Netflix, when the best show is on cable news?”
Top 5 Heal Care Stocks To Buy For 2018: Infinity Pharmaceuticals, Inc.(INFI)
Advisors’ Opinion:
- [By Lisa Levin]
In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.
- [By Lisa Levin]
In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.
- [By Lisa Levin]
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.
Top 5 Heal Care Stocks To Buy For 2018: Super Micro Computer, Inc.(SMCI)
Advisors’ Opinion:
- [By Jim Robertson]
On Friday, small cap Super Micro Computer (NASDAQ: SMCI) fell 7.52% after receivingnotification letter from Nasdaq stating that the Company is not in compliance with Nasdaq listing rule 5250(c)(1), which requires timely filing of reports with the SEC. Super Micro Computer isa global leader in high-performance, high-efficiency server technology and innovation, is a premier provider of end-to-end green computing solutions for Data Center, Cloud Computing, Enterprise IT, Hadoop/Big Data, HPC and Embedded Systems worldwide. Supermicro’s advanced Server Building Block Solutions庐 offer a vast array of components for building energy-efficient, application-optimized, computing solutions. Architecture innovations include Twin, TwinPro, FatTwin, Ultra Series, MicroCloud, MicroBlade, SuperBlade庐, Simply Double, Double-sided Storage庐, Battery Backup Power (BBP庐) modules and WIO/UIO. Products include servers, blades, GPU systems, workstations, motherboards, chassis, power supplies, storage, networking, server management software and SuperRack庐 cabinets/accessories delivering unrivaled performance and value.
Top 5 Heal Care Stocks To Buy For 2018: eLong, Inc.(LONG)
Advisors’ Opinion:
- [By Monica Gerson]
eLong, Inc. (ADR) (NASDAQ: LONG) is projected to post a quarterly loss at $0.60 per share on revenue of $38.31 million.
Qunar Cayman Islands Ltd (NASDAQ: QUNR) is expected to post a quarterly loss at $8.89 per share on revenue of $1.11 billion.
Top 5 Heal Care Stocks To Buy For 2018: North American Energy Partners, Inc.(NOA)
Advisors’ Opinion:
- [By Lisa Levin]
In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.
Top 5 Heal Care Stocks To Buy For 2018: BioCryst Pharmaceuticals Inc.(BCRX)
Advisors’ Opinion:
- [By Monica Gerson]
BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.
- [By Lisa Levin] Gainers
Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
Sorl Auto - [By Sean Williams]
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX), a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu was found in the northern part of Malaysia.
